Literature DB >> 10406925

Comparative toxicokinetics of chlorinated and brominated haloacetates in F344 rats.

I R Schultz1, J L Merdink, A Gonzalez-Leon, R J Bull.   

Abstract

Chloro, bromo, and mixed bromochloro haloacetates (HAs) are by-products of drinking water disinfection and are hepatocarcinogenic in rodents. We compared the toxicokinetics of a series of di-HAs, dichloro (DCA), bromochloro (BCA), dibromo (DBA) and tri-HAs: trichloro (TCA), bromodichloro (BDCA), chlorodibromo (CDBA), and tribromo (TBA) after iv and oral dosing (500 micrometer/kg) in male F344 rats. The blood concentrations of the HAs after iv injection declined in a bi-exponential manner with a short but pronounced distributive phase. The structural features that had the greatest influence on the disposition of HAs were substitution of a halogen for a hydrogen and the degree of bromine substitution. All di-HAs had blood elimination half-lives of less than 4 h (DCA > DBA, BCA) compared to the tri-HAs, which had half-lives that varied from 0.6 to 8.0 h (TCA > BDCA > CDBA > TBA). The urinary excretion of all di-HAs was low and accounted for less than 3% of the dose in contrast to the tri-HAs, where urinary excretion accounted for at least 30% of the dose. Toxicokinetic analysis indicated the steady-state apparent volume of distribution varied between 301 and 881 ml/kg among the HAs, but the variation was not statistically significant (P > 0.17). The blood concentration-time profiles for all di-HAs after oral dosing was complex and exhibited multiple peaks. This did not appear to be due to enterohepatic recirculation, as bile duct cannulated animals also displayed similar profiles. In contrast, the profiles for the tri-HAs did not exhibit multiple peaking after oral dosing and could be described using a one-compartment pharmacokinetic model. The oral bioavailability of the HAs varied between 30% (DBA) and 116% (TCA), depending on the number of halogen substituents and the degree of bromine substitution. In general, three patterns of elimination for the HAs can be broadly described: low metabolism with moderate renal clearance (TCA), high metabolism and renal clearance (BDCA, CDBA, TBA), and high metabolism, low renal clearance (DCA, BCA, DBA). Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10406925     DOI: 10.1006/taap.1999.8698

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  10 in total

Review 1.  Multiple peaking phenomena in pharmacokinetic disposition.

Authors:  Neal M Davies; Jody K Takemoto; Dion R Brocks; Jaime A Yáñez
Journal:  Clin Pharmacokinet       Date:  2010-06       Impact factor: 6.447

2.  Dichloroacetate- and trichloroacetate-induced oxidative stress in the hepatic tissues of mice after long-term exposure.

Authors:  Ezdihar A Hassoun; Jacquelyn Cearfoss; Jessica Spildener
Journal:  J Appl Toxicol       Date:  2010-07       Impact factor: 3.446

3.  A Mechanism-Based Pharmacokinetic Enzyme Turnover Model for Dichloroacetic Acid Autoinhibition in Rats.

Authors:  Yu Jiang; Gary Milavetz; Margaret O James; Guohua An
Journal:  J Pharm Sci       Date:  2017-02-03       Impact factor: 3.534

4.  Toxicity and carcinogenicity of the water disinfection byproduct, dibromoacetic acid, in rats and mice.

Authors:  Ronald L Melnick; Abraham Nyska; Paul M Foster; Joseph H Roycroft; Grace E Kissling
Journal:  Toxicology       Date:  2006-12-08       Impact factor: 4.221

5.  Physiologically based pharmacokinetic modeling of dibromoacetic acid in F344 rats.

Authors:  Jessica L Matthews; Irvin R Schultz; Michael R Easterling; Ronald L Melnick
Journal:  Toxicol Appl Pharmacol       Date:  2010-01-04       Impact factor: 4.219

Review 6.  Assessing exposure in epidemiologic studies to disinfection by-products in drinking water: report from an international workshop.

Authors:  Tye E Arbuckle; Steve E Hrudey; Stuart W Krasner; Jay R Nuckols; Susan D Richardson; Philip Singer; Pauline Mendola; Linda Dodds; Clifford Weisel; David L Ashley; Kenneth L Froese; Rex A Pegram; Irvin R Schultz; John Reif; Annette M Bachand; Frank M Benoit; Michele Lynberg; Charles Poole; Kirsten Waller
Journal:  Environ Health Perspect       Date:  2002-02       Impact factor: 9.031

Review 7.  Issues in the pharmacokinetics of trichloroethylene and its metabolites.

Authors:  Weihsueh A Chiu; Miles S Okino; John C Lipscomb; Marina V Evans
Journal:  Environ Health Perspect       Date:  2006-09       Impact factor: 9.031

8.  Exposure Characterization of Haloacetic Acids in Humans for Exposure and Risk Assessment Applications: An Exploratory Study.

Authors:  Shahid Parvez; Jeffrey L Ashby; Susana Y Kimura; Susan D Richardson
Journal:  Int J Environ Res Public Health       Date:  2019-02-06       Impact factor: 3.390

9.  New Perspectives for Cancer Hazard Evaluation by the Report on Carcinogens: A Case Study Using Read-Across Methods in the Evaluation of Haloacetic Acids Found as Water Disinfection By-Products.

Authors:  Stanley T Atwood; Ruth M Lunn; Sanford C Garner; Gloria D Jahnke
Journal:  Environ Health Perspect       Date:  2019-12-19       Impact factor: 9.031

10.  Low-dose pharmacokinetics and oral bioavailability of dichloroacetate in naive and GST-zeta-depleted rats.

Authors:  Shakil A Saghir; Irvin R Schultz
Journal:  Environ Health Perspect       Date:  2002-08       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.